EMD-49761

Single-particle
4.04 Å
EMD-49761
3D View Gallery
Deposition: 18/03/2025
Map released: 15/10/2025
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49761
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9ntq summary report (pdf.gz) Map and 9ntq FULL report (pdf.gz)
EMICSS annotations (xml)

Identification and non-clinical characterization of SAR444200, a novel anti-GPC3 T-cell engager, for the treatment of GPC3+ solid tumors

EMD-49761

Single-particle
4.04 Å
EMD-49761
3D View Gallery
Deposition: 18/03/2025
Map released: 15/10/2025
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Lama glama
Sample: GPC3_A0026015A08 complex
Fitted models: 9ntq

Deposition Authors: Batchelor JD, Svidritskiy E
Identification and Nonclinical Characterization of SAR444200, a Novel Anti-GPC3 NANOBODY T-cell Engager, for the Treatment of GPC3+ Solid Tumors.
Meoni P, Vintem APB, Cortez-Retamozo VF, Jacobs J, De Tavernier E, Fiorentini P, Van Hoorick D, Batchelor JD, Svidritskiy E, Qiu Y, Dejonckheere E, Li A, Pao LI, Buyse MA
(2026) Mol.Cancer Ther. , 25 , 361 - 370
PUBMED: 41041827
DOI: doi:10.1158/1535-7163.MCT-24-1049
ISSN: 1538-8514
Grant Support: